
SHANGHAI, July 21, 2025 /PRNewswire/ — KEENON Robotics continues to secure the #1 global position in the commercial service robot market, holding the No. 1 rank worldwide by shipment share, according to the latest reports from IDC, a premier IT market intelligence firm. Released on July 18, the Global Commercial Delivery Service Robot Market Share 2024 and Global Commercial Cleaning Robot Market Share 2024 reports highlight KEENON Robotics’ continued industry leadership, securing the No.1 position in both the global delivery service robot and food delivery robot segments.
In 2024, the commercial service robot market maintained steady growth, with Chinese vendors contributing 84.7% of global shipments. According to IDC, KEENON Robotics claimed the top spot globally with a 22.7% shipment share, driven by its comprehensive product lineup spanning delivery, cleaning, disinfection, and guiding robots. The company’s flagship delivery robots are widely deployed across the foodservice, healthcare, and hospitality sectors.
The global delivery service robot market is expanding rapidly, with KEENON Robotics leading the sector at a 29.8% market share. The company also dominates the food delivery robot segment, capturing a commanding 40.4% share and ranking #1 in both shipments and revenue—further solidifying its industry leadership.
About KEENON Robotics
A global leader in commercial service robots and solutions, KEENON Robotics has been at the forefront of the advanced service robot market since 2010. Harnessing cutting-edge technologies in robotics and cloud computing, the company is trusted by businesses worldwide. KEENON Robotics is dedicated to creating value, fostering innovation, and contributing to industry growth across various sectors.
SOURCE KEENON Robotics
More Stories
Selon IDC, KEENON Robotics conserve sa position de leader mondial sur le marché des robots de service commerciaux, en obtenant trois premières places USA – Français APAC – Traditional Chinese USA – English India – English
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias
TCAI es el primero en EE.UU. en utilizar un novedoso sistema inalámbrico para tratar arritmias cardíacas